Rocket Pharmaceuticals Inc RCKT
News
Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
Rocket Pharmaceuticals Shares Slide After FDA Rejects Kresladi
FDA Turns Away Rocket Pharma's Gene Therapy, Seeks More Data
FDA Extends Review of Rocket Pharma's Proposed Kresladi
Rocket Pharmaceuticals Stock Surges 34% on FDA Alignment for Danon Disease Treatment
Rocket Pharmaceuticals Reaches FDA Alignment in Danon Heart Disease Treatment Trial